We use cookies to customise content for your subscription and for analytics. If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
The Food and Drug Administration (FDA) releases a final guide dated February 2012 titled “Guidance for Industry: Early Clinical Trials with Live Biotherapeutic Products: Chemistry, Manufacturing, and Control Information.”
The U.S. Patent and Trademark Office (USPTO) has scheduled a November 29, 2011, meeting in Alexandria, Virginia, to bring together industry stakeholders and patent examiners and directors “to share ideas, experiences, and insights on best practices in advancing prosecution and provide a forum for discussion on how the agency can improve and expand its relationship with the medical device technology community.”
